Biomedicines (Aug 2024)

Role of miRNA–mRNA Interactome in Pathophysiology of Arrhythmogenic Cardiomyopathy

  • Fernando Bonet,
  • Oscar Campuzano,
  • José Córdoba-Caballero,
  • Mireia Alcalde,
  • Georgia Sarquella-Brugada,
  • Aitana Braza-Boïls,
  • Ramon Brugada,
  • Francisco Hernández-Torres,
  • Maribel Quezada-Feijoo,
  • Monica Ramos,
  • Alipio Mangas,
  • Juan A. G. Ranea,
  • Rocío Toro

DOI
https://doi.org/10.3390/biomedicines12081807
Journal volume & issue
Vol. 12, no. 8
p. 1807

Abstract

Read online

Arrhythmogenic cardiomyopathy is an inherited entity characterized by irregular cell–cell adhesion, cardiomyocyte death and fibro-fatty replacement of ventricular myocytes, leading to malignant ventricular arrythmias, contractile dysfunction and sudden cardiac death. Pathogenic variants in genes that encode desmosome are the predominant cause of arrhythmogenic cardiomyopathy. Moreover, signalling pathways such as Wnt/ß-catenin and transforming growth factor-β have been involved in the disease progression. However, still little is known about the molecular pathophysiological mechanisms that underlie arrhythmogenic cardiomyopathy pathogenesis. We used mRNA and small RNA sequencing to analyse the transcriptome of health and arrhythmogenic cardiomyopathy of autopsied human hearts. Our results showed 697 differentially expressed genes and eight differentially expressed miRNAs. Functional enrichment revealed mitochondrial respiratory-related pathways, impaired response to oxidative stress, apoptotic signalling pathways and inflammatory response-related and extracellular matrix response pathways. Furthermore, analysis of the miRNA–mRNA interactome identified eleven negatively correlated miRNA-target pairs for arrhythmogenic cardiomyopathy. Our finding revealed novel arrhythmogenic cardiomyopathy-related miRNAs with important regulatory function in disease pathogenesis, highlighting their value as potential key targets for therapeutic approaches.

Keywords